287.3K XNAS Volume
XNAS 17 Apr, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Alumis Inc. is on 30 Apr 2025 for the purpose of Alumis Inc Annual General Meeting for 2024
See details
Alumis Inc. Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
Expensive Valuation
Technically Bearish
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
6Positive9Negative
40.0% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Alumis Inc. Stock Price Analysis
Day Price Range | 5 (LTP) 4.85.3 LowHigh |
Week Price Range | 5 (LTP) 4.86.5 LowHigh |
Month Price Range | 5 (LTP) 3.310.5 LowHigh |
Alumis Inc. Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Alumis Inc. Stock Analysis
Alumis Inc. stock analysis with key metrics, changes, and trends.
Alumis Inc. Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Net Profit | $294.23 M | 89.84% | negative |
| |
Price to Earning Ratio | -0.92 | - | negative |
| |
Stock Price | $5.00 | -22.84% | negative |
| |
Quarterly Net profit | $94.76 M | 141.12% | negative |
| |
Debt to Equity Ratio | 0.12 | - | positive |
| |
Mutual Fund Holding | 8.76 % | 0.8% | positive |
| |
Institutional Holding | 54.44 % | 0.01% | positive |
|
Loading data..
Alumis Inc. - Company Profile
What does Alumis Inc. do?
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
Alumis Inc. Board of directors
All Gross Remunerations are in USD